The objective of this work was to determine whether overweight/obesity is a risk factor for cerebrovascular disease in children.
The association between adult obesity and cerebrovascular disease, specifically arterial ischemic stroke and cerebral sinovenous thrombosis, is well characterized. Multiple studies report that elevated body mass index is an independent risk factor for arterial ischemic stroke in adults. 1, 2 Similarly, elevated body mass index serves as a risk factor for venous thromboembolism in adults. 3 The risk factors for cerebral sinovenous thrombosis and arterial ischemic stroke in children are well described in several cohorts. [4] [5] [6] Although thrombophilia is well characterized by multiple studies as a risk factor for childhood arterial ischemic stroke, 7 and recent studies have established a relationship between thrombophilia and obesity, 8 few studies have investigated the influence of body mass index as a risk factor for childhood vascular disease. 9 Given that obesity is increasingly prevalent in children 10 and is associated with venous thromboembolism and arterial ischemic stroke in adults, the objective of this current work was to determine whether overweight/obesity is a risk factor for cerebrovascular disease in children.
Patients and Methods
Data on height, weight, and presenting characteristics were prospectively collected on children between the ages of 2 to 18 years (inclusive) with clinically diagnosed and radiologically confirmed cerebral sinovenous thrombosis (n ¼ 23) or arterial ischemic stroke (n ¼ 30) enrolled in an institutional review board-approved institution-based prospective inception cohort study between August 2006 and August 2009 at the Children's Hospital, Colorado (Aurora, Colorado, USA). Body mass index was calculated using the most recent height and weight available within 4 weeks of hospital admission. Thrombotic characteristics were analyzed for each study participant in the arterial ischemic stroke and cerebral sinovenous thrombosis cohorts in order to classify the participants into 3 groups: no thrombophilia, potent thrombophilia, and mild thrombophilia. Potent thrombophilia included any one of the following: (1) severe anticoagulant deficiency (<30% antithrombin; <20% protein C or protein S); (2) homozygosity for the factor V Leiden or prothrombin G20210A polymorphisms; (3) antiphospholipid antibody syndrome; or (4) multitrait (>1) thrombophilia. All other thrombophilia states were characterized as ''mild thrombophilia.'' Children with potential body mass index confounders, including congenital heart disease (n ¼ 5) and cancer (n ¼ 1), were excluded from the cohort analysis. Body mass index percentiles adjusted for age and sex were generated using Centers for Disease Control and Prevention growth charts. 11 Body mass index percentiles were then classified into the following categories adjusted for age and sex: (1) overweight/obesity: body mass index 85th percentile and (2) normal/underweight: body mass index <85th percentile.
Prevalence of overweight/obesity was compared between cohort patients and each of 2 control groups: (1) healthy children, aged 2 to 19 years, from the National Health and Nutrition Examination Survey conducted in 2007-2008 (n ¼ 3281) and (2) 
Results
Demographics and clinical characteristics of the patient cohort are given in the table. Overweight/obesity was significantly higher in cerebral sinovenous thrombosis patients relative to both the National Health and Nutrition Examination Survey controls (P ¼ .04) and the Colorado controls (P ¼ .02). In contrast, the prevalence did not differ between the arterial ischemic stroke patients and National Health and Nutrition Examination Survey controls (P ¼ .81). As demonstrated in the figure, there was a tendency toward higher body mass index percentile in cerebral sinovenous thrombosis patients (mean ¼ 69.6%, SE ¼ 6.65) compared to Colorado controls (mean ¼ 54.7%; SE ¼ 3.78; P ¼ .06). There were no significant differences in thrombophilia characteristics between the 2 cohorts.
Discussion
The present findings, from a single-institution prospective cohort of children with cerebrovascular disease, indicate that prevalence of overweight/obesity is increased in those with cerebral sinovenous thrombosis in comparison to both National Health and Nutrition Examination Survey pediatric norms and contemporaneous, hospitalized local controls. This observation is supported by previous data demonstrating overweight/obesity as a modest risk factor for adult venous thromboembolism. 3 Although previous publications have postulated an association between childhood overweight/obesity and cerebral sinovenous thrombosis, 9 none have directly addressed the relationship between childhood overweight/obesity and cerebral sinovenous thrombosis, presumably because of a lack of statistical power. The pathophysiological mechanisms underlying an association between overweight/obesity and thrombogenesis have not yet been clearly defined. Hypofibrinolytic states and an associated elevation in plasminogen activator inhibitor-1 among overweight adults with cerebral sinovenous thrombosis have been shown, but this relationship is still controversial. 12 Additionally, recent studies have demonstrated a relationship between obesity and a prothrombotic state. 8 Potential factors, including protein C resistance, elevated levels of factor VIII, and markers of inflammation, should be investigated in obese children with cerebral sinovenous thrombosis.
The principal limitation of the present study is the relatively small patient cohort, which is susceptible to bias. Additionally, given the single-institutional site of the study and small sample size, the findings may not be generalizable to other geographical locations and are best applied to clinical populations exhibiting demographic characteristics similar to those observed in our cohort. As an example of this, males are likely overrepresented in the arterial ischemic stroke cohort (number of males: 21/25, 84%). For these reasons, substantiation of these results in broader patient populations is warranted.
